Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

- Click on the first letter of the keyword:
  - A
  - B
  - C
  - D
  - E
  - F
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - Other

Search results for: G
Results 191 - 200 of 306 shown below

Glasgow osteosarcoma

T G Granda, R-M D'Attino, E Filipski, P Vrignaud, C Garufi, E Terzoli, M-C Bissery and F Lévi

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma

doi:10.1038/sj.bjc.6600168

Abstract | Full article | PDF
X M Li, K Tanaka, J Sun, E Filipski, L Kayitalire, C Focan and F Lévi

Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin

advance online publication, 2005-04-19 00:00:00.000;

doi:10.1038/sj.bjc.6602564

Abstract | Full article | PDF
GLC₄

D J A de Groot, T Timmer, D C J Spierings, T K P Le, S de Jong and E G E de Vries

Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells

advance online publication, 2005-04-05 00:00:00.000;

doi:10.1038/sj.bjc.6602516

Abstract | Full article | PDF
Gleason grade

L Lessard, L R Bégin, M E Gleave, A-M Mes-Masson and F Saad

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

advance online publication, 2005-10-04 00:00:00.000;

doi:10.1038/sj.bjc.6602796

Abstract | Full article | PDF
M J Baker, E Gazi, M D Brown, J H Shanks, P Gardner and N W Clarke

FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer

advance online publication, 2008-11-04 00:00:00.000;

doi:10.1038/sj.bjc.6604753

Abstract | Full article | PDF
Gleason score

P Crow, N Stone, C A Kendall, J S Uff, J A M Farmer, H Barr and M P J Wright

The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro

doi:10.1038/sj.bjc.6601059

Abstract | Full article | PDF
P A McArdle, D C McMillan, N Sattar, A M Wallace and M A Underwood

The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease

advance online publication, 2004-10-26 00:00:00.000;

doi:10.1038/sj.bjc.6602211

Abstract | Full article | PDF
Gleevec

J Topaly, S Fruehauf, A D Ho and W J Zeller

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

doi:10.1038/sj.bjc.6600242

Abstract | Full article | PDF
Glial fibrillary acidic protein

J C Nicholson, F M Ross, J A Kohler and D W Ellison

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours

doi:10.1038/sj.bjc.6690525

Abstract | Full article | PDF
glioblastoma

X-X Tian, JC-S Pang, J Zheng, J Chen, S S T To and H-K Ng

Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length

doi:10.1038/sj.bjc.6600244

Abstract | Full article | PDF
N Cordes, B Hansmeier, C Beinke, V Meineke and D van Beuningen

Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines

doi:10.1038/sj.bjc.6601429

Abstract | Full article | PDF
L Juillerat-Jeanneret, J Celerier, C Chapuis Bernasconi, G Nguyen, W Wostl, H P Maerki, R-C Janzer, P Corvol and J-M Gasc

Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

doi:10.1038/sj.bjc.6601646

Abstract | Full article | PDF
O Arrieta, P Guevara, E Escobar, R García-Navarrete, B Pineda and J Sotelo

Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma

advance online publication, 2005-03-22 00:00:00.000;

doi:10.1038/sj.bjc.6602483

Abstract | Full article | PDF
K Ogawa, Y Yoshii, O Inoue, T Toita, A Saito, Y Kakinohana, G Adachi, S Iraha, W Tamaki, K Sugimoto, A Hyodo and S Murayama

Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas

advance online publication, 2006-09-05 00:00:00.000;

doi:10.1038/sj.bjc.6603342

Abstract | Full article | PDF
M Mauer, R Stupp, M J B Taphoorn, C Coens, D Osoba, C Marosi, R Wong, O de Witte, J G Cairncross, F Efficace, R O Mirimanoff, P Forsyth, M J van den Bent, M Weller and A Bottomley

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

advance online publication, 2007-07-03 00:00:00.000;

doi:10.1038/sj.bjc.6603876

Abstract | Full article | PDF
M R Graf, W Jia and R M Loria

The neuro-steroid, 3 androstene 17 diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways

advance online publication, 2007-07-17 00:00:00.000;

doi:10.1038/sj.bjc.6603894

Abstract | Full article | PDF
K R Swanson, R C Rostomily and E C Alvord

A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle

advance online publication, 2007-12-04 00:00:00.000;

doi:10.1038/sj.bjc.6604125

Abstract | Full article | PDF
M Szybka, I Zawlik, D Kulczycka, E Golanska, E Jesien, D Kupnicka, R Stawski, S Piaskowski, E Bieniek, M Zakrzewska, R Kordek, P P Liberski and P Rieske

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53

advance online publication, 2008-03-18 00:00:00.000;

doi:10.1038/sj.bjc.6604258

Abstract | Full article | PDF
D M Ashley, C D Riffkin, M M Lovric, T Mikeska, A Dobrovic, J A Maxwell, H S Friedman, K J Drummond, A H Kaye, H K Gan, T G Johns and C J Hawkins

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs

advance online publication, 2008-07-01 00:00:00.000;

doi:10.1038/sj.bjc.6604459

Abstract | Full article | PDF
C E Furneaux, E S Marshall, K Yeoh, S J Monteith, P J Mews, C A Sansur, R J Oskouian, K J Sharples and B C Baguley

Cell cycle times of short-term cultures of brain cancers as predictors of survival

advance online publication, 2008-10-14 00:00:00.000;

doi:10.1038/sj.bjc.6604716

Abstract | Full article | PDF
W Chearwae and J J Bright

PPAR agonists inhibit growth and expansion of CD133+ brain tumour stem cells

advance online publication, 2008-11-18 00:00:00.000;

doi:10.1038/sj.bjc.6604786

Abstract | Full article | PDF
B Fuh, M Sobo, L Cen, D Josiah, B Hutzen, K Cisek, D Bhasin, N Regan, L Lin, C Chan, H Caldas, S DeAngelis, C Li, P-K Li and J Lin

LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model

doi:10.1038/sj.bjc.6604793

Abstract | Full article | PDF
J Dunn, A Baborie, F Alam, K Joyce, M Moxham, R Sibson, D Crooks, D Husband, A Shenoy, A Brodbelt, H Wong, T Liloglou, B Haylock and C Walker

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

advance online publication, 2009-06-16 00:00:00.000;

doi:10.1038/sj.bjc.6605127

Abstract | Full article | PDF
M D Groves, V K Puduvalli, M R Gilbert, V A Levin, C A Conrad, V H Liu, K Hunter, C Meyers, K R Hess and W K Alfred Yung

Two phase II trials of temozolomide with interferon-2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme

doi:10.1038/sj.bjc.6605189

Abstract | Full article | PDF
D A Reardon, G Dresemann, S Taillibert, M Campone, M van den Bent, P Clement, E Blomquist, L Gordower, H Schultz, J Raizer, P Hau, J Easaw, M Gil, J Tonn, A Gijtenbeek, U Schlegel, P Bergstrom, S Green, A Weir and Z Nikolova

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

advance online publication, 2009-11-10 00:00:00.000;

doi:10.1038/sj.bjc.6605411

Abstract | Full article | PDF
D A Reardon, A Desjardins, J J Vredenburgh, S Gururangan, J H Sampson, S Sathornsumetee, R E McLendon, J E Herndon, J E Marcello, J Norfleet, A H Friedman, D D Bigner and H S Friedman

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

advance online publication, 2009-11-17 00:00:00.000;

doi:10.1038/sj.bjc.6605412

Abstract | Full article | PDF
X X Tian, J Y H Chan, J C S Pang, J Chen, J H He, T S S To, S F Leung and H K Ng

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor

doi:10.1038/sj.bjc.6690798

Abstract | Full article | PDF
A Miyakawa, K Ichimura, E E Schmidt, S Varmeh-Ziaie and V P Collins

Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours

doi:10.1054/bjoc.1999.0961

Abstract | Full article | PDF
M I Koukourakis, S Koukouraki, I Fezoulidis, N Kelekis, G Kyrias, S Archimandritis and N Karkavitsas

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

doi:10.1054/bjoc.2000.1459

Abstract | Full article | PDF
F Ria, M Landriscina, F Remiddi, R Rosselli, M Iacoangeli, M Scerrati, G Pani, S Borrello and T Galeotti

The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications

doi:10.1054/bjoc.2000.1594

Abstract | Full article | PDF
A Tchirkov, C Rolhion, S Bertrand, J-F Doré, J-J Dubost and P Verrelle

IL-6 gene amplification and expression in human glioblastomas

doi:10.1054/bjoc.2001.1942

Abstract | Full article | PDF
glioblastoma multiforme

J Dinnes, C Cave, S Huang and R Milne

A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma

doi:10.1038/sj.bjc.6600135

Abstract | Full article | PDF
J Hu, JC-s Pang, CY-k Tong, B Lau, X-l Yin, W-S Poon, C-C Jiang, L-F Zhou and H-K Ng

High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours

doi:10.1038/sj.bjc.6600430

Abstract | Full article | PDF
A Tchirkov, C Rolhion, J-L Kémény, B Irthum, S Puget, T Khalil, O Chinot, F Kwiatkowski, B Périssel, P Vago and P Verrelle

Clinical implications of quantitative real-time RT–PCR analysis of hTERT gene expression in human gliomas

doi:10.1038/sj.bjc.6600754

Abstract | Full article | PDF
B Fazeny-Dörner, M Veitl, C Wenzel, K Rössler, K Ungersböck, K Dieckmann, M Piribauer, J Hainfellner and C Marosi

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme

doi:10.1038/sj.bjc.6600769

Abstract | Full article | PDF
C Bauréus-Koch, G Nyberg, B Widegren, L G Salford and B R R Persson

Radiation sterilisation of cultured human brain tumour cells for clinical immune tumour therapy

doi:10.1038/sj.bjc.6601467

Abstract | Full article | PDF
M R Zalutsky

Targeted radiotherapy of brain tumours

advance online publication, 2004-04-06 00:00:00.000;

doi:10.1038/sj.bjc.6601771

Abstract | Full article | PDF
M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria

A pilot clinical study of ⁹-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

advance online publication, 2006-06-27 00:00:00.000;

doi:10.1038/sj.bjc.6603236

Abstract | Full article | PDF
A Tchirkov, T Khalil, E Chautard, K Mokhtari, L Véronèse, B Irthum, P Vago, J-L Kémény and P Verrelle

Interleukin-6 gene amplification and shortened survival in glioblastoma patients

advance online publication, 2007-01-16 00:00:00.000;

doi:10.1038/sj.bjc.6603586

Abstract | Full article | PDF
M Schmitz, A Temme, V Senner, R Ebner, S Schwind, S Stevanovic, R Wehner, G Schackert, H K Schackert, M Fussel, M Bachmann, E P Rieber and B Weigle

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

advance online publication, 2007-03-20 00:00:00.000;

doi:10.1038/sj.bjc.6603696

Abstract | Full article | PDF
A Diaz Miqueli, J Rolff, M Lemm, I Fichtner, R Perez and E Montero

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies

doi:10.1038/sj.bjc.6604943

Abstract | Full article | PDF
X Mao, I Tomlinson, J-I Mao, M Noble and D Sheer

Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line

doi:10.1038/sj.bjc.6690116

Abstract | Full article | PDF
E Galanis and J Buckner

Chemotherapy for high-grade gliomas

doi:10.1054/bjoc.1999.1075

Abstract | Full article | PDF
W K A Yung, R E Albright, J Olson, R Fredericks, K Fink, M D Prados, M Brada, A Spence, R J Hohl, W Shapiro, M Glantz, H Greenberg, R G Selker, N A Vick, R Rampling, H Friedman, P Phillips, J Bruner, N Yue, D Osoba, S Zaknoen and V A Levin

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

doi:10.1054/bjoc.2000.1316

Abstract | Full article | PDF
glioma

K R Swanson, E C Alvord and J D Murray

Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy

doi:10.1038/sj.bjc.6600021

Abstract | Full article | PDF
C Grana, M Chinol, C Robertson, C Mazzetta, M Bartolomei, C De Cicco, M Fiorenza, M Gatti, P Caliceti and G Paganelli

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study

doi:10.1038/sj.bjc.6600047

Abstract | Full article | PDF
N Shinoura, S Sakurai, F Shibasaki, A Asai, T Kirino and H Hamada

Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas

doi:10.1038/sj.bjc.6600061

Abstract | Full article | PDF
M L Turcotte, M Parliament, A Franko and J Allalunis-Turner

Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells

doi:10.1038/sj.bjc.6600087

Abstract | Full article | PDF
F J T Staal, R B van der Luijt, M R M Baert, J van Drunen, H van Bakel, E Peters, I de Valk, H K P van Amstel, M J B Taphoorn, G H Jansen, C W M van Veelen, B Burgering and G E J Staal

A novel germline mutation of PTEN associated with brain tumours of multiple lineages

doi:10.1038/sj.bjc.6600206

Abstract | Full article | PDF
P Mukherjee, M M El-Abbadi, J L Kasperzyk, M K Ranes and T N Seyfried

Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model

doi:10.1038/sj.bjc.6600298

Abstract | Full article | PDF
S Saadoun, M C Papadopoulos, D C Davies, B A Bell and S Krishna

Increased aquaporin 1 water channel expression inhuman brain tumours

doi:10.1038/sj.bjc.6600512

Abstract | Full article | PDF
T Sasaki, K Yamazaki, T Yamori and T Endo

Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin

doi:10.1038/sj.bjc.6600550

Abstract | Full article | PDF
W Günther, E Pawlak, R Damasceno, H Arnold and A J Terzis

Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids

doi:10.1038/sj.bjc.6600711

Abstract | Full article | PDF
B Fazeny-Dörner, M Veitl, C Wenzel, K Rössler, K Ungersböck, K Dieckmann, M Piribauer, J Hainfellner and C Marosi

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme

doi:10.1038/sj.bjc.6600769

Abstract | Full article | PDF
S Zoula, P F J W Rijken, J P W Peters, R Farion, B P J Van der Sanden, A J Van der Kogel, M Décorps and C Rémy

Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection

doi:10.1038/sj.bjc.6600837

Abstract | Full article | PDF
T Komata, T Kanzawa, H Takeuchi, I M Germano, M Schreiber, Y Kondo and S Kondo

Antitumour effect of cyclin-dependent kinase inhibitors (p16^INK4A, p18^INK4C, p19^INK4D, p21^WAF1/CIP1 and p27^KIP1) on malignant glioma cells

doi:10.1038/sj.bjc.6600862

Abstract | Full article | PDF
M Kim, L A Sumerel, N Belousova, G R Lyons, D E Carey, V Krasnykh and J T Douglas

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

doi:10.1038/sj.bjc.6600932

Abstract | Full article | PDF
E S Newlands, T Foster and S Zaknoen

Phase 1 study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

doi:10.1038/sj.bjc.6601043

Abstract | Full article | PDF
D Frappaz, O Chinot, A Bataillard, M Ben Hassel, L Capelle, S Chanalet, M Chatel, D Figarella-Branger, Y Guegan, J Guyotat, K Hoang-Xuan, E Jouanneau, F Keime-Guibert, C Laforêt, C Linassier, H Loiseau, J P Maire, P Menei, S Rousmans, M Sanson and M P Sunyach

Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)

doi:10.1038/sj.bjc.6601087

Abstract | Full article | PDF
G Driessens, L Harsan, B Robaye, D Waroquier, P Browaeys, X Giannakopoulos, T Velu and C Bruyns

Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour

doi:10.1038/sj.bjc.6601163

Abstract | Full article | PDF
T Kanzawa, I M Germano, Y Kondo, H Ito, S Kyo and S Kondo

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide

doi:10.1038/sj.bjc.6601193

Abstract | Full article | PDF
R Yamanaka, T Abe, N Yajima, N Tsuchiya, J Homma, T Kobayashi, M Narita, M Takahashi and R Tanaka

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

doi:10.1038/sj.bjc.6601268

Abstract | Full article | PDF
T N Seyfried, T M Sanderson, M M El-Abbadi, R McGowan and P Mukherjee

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer

doi:10.1038/sj.bjc.6601269

Abstract | Full article | PDF
H Takeuchi, T Kanzawa, Y Kondo and S Kondo

Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells

doi:10.1038/sj.bjc.6601605

Abstract | Full article | PDF
M R Zalutsky

Targeted radiotherapy of brain tumours

advance online publication, 2004-04-06 00:00:00.000;

doi:10.1038/sj.bjc.6601771

Abstract | Full article | PDF
S Rutkowski, S De Vleeschouwer, E Kaempgen, J E A Wolff, J Kühl, P Demaerel, M Warmuth-Metz, P Flamen, F Van Calenbergh, C Plets, N Sörensen, A Opitz and S W Van Gool

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

advance online publication, 2004-10-12 00:00:00.000;

doi:10.1038/sj.bjc.6602195

Abstract | Full article | PDF
J Sabatier, E Uro-Coste, I Pommepuy, F Labrousse, S Allart, M Trémoulet, M B Delisle and P Brousset

Detection of human cytomegalovirus genome and gene products in central nervous system tumours

advance online publication, 2005-02-08 00:00:00.000;

doi:10.1038/sj.bjc.6602339

Abstract | Full article | PDF
L M Bäcklund, B R Nilsson, L Liu, K Ichimura and V P Collins

Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas

advance online publication, 2005-06-21 00:00:00.000;

doi:10.1038/sj.bjc.6602661

Abstract | Full article | PDF
M P W A Houben, J W W Coebergh, R M C Herings, M K Casparie, C C Tijssen, C M van Duijn and B H Ch Stricker

The association between antihypertensive drugs and glioma

advance online publication, 2006-02-21 00:00:00.000;

doi:10.1038/sj.bjc.6603000

Abstract | Full article | PDF
J R Dunn, J E Reed, D G du Plessis, E J Shaw, P Reeves, A L Gee, P Warnke and C Walker

Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours

advance online publication, 2006-03-28 00:00:00.000;

doi:10.1038/sj.bjc.6603006

Abstract | Full article | PDF
C Wibom, F Pettersson, M Sjöström, R Henriksson, M Johansson and A T Bergenheim

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment

advance online publication, 2006-05-30 00:00:00.000;

doi:10.1038/sj.bjc.6603190

Abstract | Full article | PDF
K Ogawa, Y Yoshii, O Inoue, T Toita, A Saito, Y Kakinohana, G Adachi, S Iraha, W Tamaki, K Sugimoto, A Hyodo and S Murayama

Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas

advance online publication, 2006-09-05 00:00:00.000;

doi:10.1038/sj.bjc.6603342

Abstract | Full article | PDF
T Takebayashi, N Varsier, Y Kikuchi, K Wake, M Taki, S Watanabe, S Akiba and N Yamaguchi

Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case–control study

advance online publication, 2008-02-05 00:00:00.000;

doi:10.1038/sj.bjc.6604214

Abstract | Full article | PDF
V S Benson, K Pirie, J Green, D Casabonne and V Beral

Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort

advance online publication, 2008-06-17 00:00:00.000;

doi:10.1038/sj.bjc.6604445

Abstract | Full article | PDF
D M Ashley, C D Riffkin, M M Lovric, T Mikeska, A Dobrovic, J A Maxwell, H S Friedman, K J Drummond, A H Kaye, H K Gan, T G Johns and C J Hawkins

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs

advance online publication, 2008-07-01 00:00:00.000;

doi:10.1038/sj.bjc.6604459

Abstract | Full article | PDF
I V Ulasov, A M Sonabend, S Nandi, A Khramtsov, Y Han and M S Lesniak

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo

advance online publication, 2009-03-10 00:00:00.000;

doi:10.1038/sj.bjc.6604969

Abstract | Full article | PDF
J Dunn, A Baborie, F Alam, K Joyce, M Moxham, R Sibson, D Crooks, D Husband, A Shenoy, A Brodbelt, H Wong, T Liloglou, B Haylock and C Walker

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

advance online publication, 2009-06-16 00:00:00.000;

doi:10.1038/sj.bjc.6605127

Abstract | Full article | PDF
C Palma, F Nardelli, S Manzini and C A Maggi

Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK₁ receptors

doi:10.1038/sj.bjc.6690039

Abstract | Full article | PDF
H Kishima, K Shimizu, K Tamura, Y Miyao, E Mabuchi, E Tominaga, J Matsuzaki and T Hayakawa

Monoclonal antibody ONS-M21 recognizes integrin 3 in gliomas and medulloblastomas

doi:10.1038/sj.bjc.6690053

Abstract | Full article | PDF
M P A Davies, F E M Gibbs, N Halliwell, K A Joyce, M M Roebuck, M L Rossi, J Salisbury, D R Sibson, L Tacconi and C Walker

Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas

doi:10.1038/sj.bjc.6690246

Abstract | Full article | PDF
M J Allalunis-Turner, A J Franko and M B Parliament

Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia

doi:10.1038/sj.bjc.6690328

Abstract | Full article | PDF
M Johansson, A T Bergenheim, A Widmark and R Henriksson

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma

doi:10.1038/sj.bjc.6690333

Abstract | Full article | PDF
D F Emerich, P Snodgrass, R Dean, M Agostino, B Hasler, M Pink, H Xiong, B S Kim and R T Bartus

Enhanced delivery of carboplatin into brain tumours with intravenous Cereport^TM (RMP-7): dramatic differences and insight gained from dosing parameters

doi:10.1038/sj.bjc.6690450

Abstract | Full article | PDF
V Doireau, J Grill, M Zerah, A Lellouch-Tubiana, D Couanet, P Chastagner, J C Marchal, Y Grignon, Z Chouffai and C Kalifa

Chemotherapy for unresectable and recurrent intramedullary glial tumours in children

doi:10.1038/sj.bjc.6690772

Abstract | Full article | PDF
R J Mairs, C L Wideman, W J Angerson, T L Whateley, M S Reza, J R Reeves, L M Robertson, A Neshasteh-Riz, R Rampling, J Owens, D Allan and D I Graham

Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

doi:10.1054/bjoc.1999.0879

Abstract | Full article | PDF
C Palma, M Bigioni, C Irrissuto, F Nardelli, C A Maggi and S Manzini

Anti-tumour activity of tachykinin NK₁receptor antagonists on human glioma U373 MG xenograft

doi:10.1054/bjoc.1999.0946

Abstract | Full article | PDF
C S Brock, H Young, S M O'Reilly, J Matthews, S Osman, H Evans, E S Newlands and P M Price

Early evaluation of tumour metabolic response using [¹⁸F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

doi:10.1054/bjoc.1999.0971

Abstract | Full article | PDF
M B Parliament, M J Allalunis-Turner, A J Franko, P L Olive, R Mandyam, C Santos and B Wolokoff

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours

doi:10.1054/bjoc.1999.0975

Abstract | Full article | PDF
D Sanoudou, O Tingby, M A Ferguson-Smith, V P Collins and N Coleman

Analysis of pilocytic astrocytoma by comparative genomic hybridization

doi:10.1054/bjoc.1999.1066

Abstract | Full article | PDF
S Takano, K Tsuboi, Y Tomono, Y Mitsui and T Nose

Tissue factor, osteopontin, _v₃integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression

doi:10.1054/bjoc.2000.1150

Abstract | Full article | PDF
M Johansson, R Henriksson, A T Bergenheim and L-O D Koskinen

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma

doi:10.1054/bjoc.2000.1354

Abstract | Full article | PDF
B Malmer, L Iselius, E Holmberg, A Collins, R Henriksson and H Grönberg

Genetic epidemiology of glioma

doi:10.1054/bjoc.2000.1612

Abstract | Full article | PDF
M K Ranes, M El-Abbadi, M G Manfredi, P Mukherjee, F M Platt and T N Seyfried

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

doi:10.1054/bjoc.2000.1713

Abstract | Full article | PDF
C-C Chio, Y-S Wang, Y-L Chen, S-J Lin and B-C Yang

Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice

doi:10.1054/bjoc.2001.2055

Abstract | Full article | PDF
E Rivera, O Arrieta, P Guevara, A Duarte-Rojo and J Sotelo

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

doi:10.1054/bjoc.2001.2102

Abstract | Full article | PDF
S Balesaria, C Brock, M Bower, J Clark, S K Nicholson, P Lewis, S de Sanctis, H Evans, D Peterson, N Mendoza, M G Glaser, E S Newlands and R A Fisher

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas

doi:10.1038/sj.bjc.6693403

Abstract | Full article | PDF
glioma c6

L Greenbaum, Y Gozlan, D Schwartz, D J Katcoff and Z Malik

Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation?

doi:10.1038/sj.bjc.6600173

Abstract | Full article | PDF